All

Scipio bioscience announces its seed funding of €1.2m obtained from Seventure Partners’ Quadrivium I seed fund and High-Tech Gründerfonds
14 November 2017

Scipio bioscience announces its seed funding of €1.2m obtained from Seventure Partners’ Quadrivium I seed fund and High-Tech Gründerfonds

Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces...

Read the press release
Enterome’s EB8018, a first-in-class drug candidate targeting Crohn’s disease, successfully completes Phase I study in healthy volunteers
30 October 2017

Enterome’s EB8018, a first-in-class drug candidate targeting Crohn’s disease, successfully completes Phase I study in healthy volunteers

ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, is pleased to announce the successful completion of the first Phase 1 clinical study with its...

Read the press release
Seventure’s Health for Life Capital™ participates in $26.1m financing of Europe’s largest digital health provider, Push Doctor
6 July 2017

Seventure’s Health for Life Capital™ participates in $26.1m financing of Europe’s largest digital health provider, Push Doctor

Europe’s largest digital health provider, Push Doctor, announces that it has raised $26.1M in a Series B funding round led by Accelerated Digital Ventures (“ADV” – the...

Read the press release

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse